Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Adil Daud Thomas Kurt Eigentler Paolo Antonio Ascierto Alexander M. M. Eggermont Jacob Schachter F Stephen Hodi Tara C Gangadhar Ronnie Shapira-Frommer Antoni Ribas Matteo Carlino Christian U Blank Reinhard Dummer Jedd D. Wolchok Caroline Robert Dirk Schadendorf |
| Publication date | June 23, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |